India's first and only mRNA vaccine against Covid-19 on Tuesday received regulatory approval for advanced clinical trials to examine its protective efficacy, raising the hopes of its availability for public use after a few months.

“It is a matter of pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India has approved the phase II/III trial. This is an important milestone in our indigenous vaccine development mission and positions India on the global map for novel vaccine development,” said Renu Swarup, Secretary, DBT.

Read more at https://www.deccanherald.com/national/indias-first-mrna-covid-vacci...